Concepedia

Minyi Qian

MQ

Statistics

Publications

16

Citations

573

H-Index

13

Active since

2015

Affiliations

China Pharmaceutical University(Current)

Nanjing University of Chinese Medicine

Nanjing University

Capital Medical University

Beijing Ditan Hospital

Minyi Qian is an author at China Pharmaceutical University specializing in life sciences, pharmacology, and liver disease.

ORCID

Publications per year

2015–2025

16

Publications

16

Amlodipine, an anti‐hypertensive drug, alleviates non‐alcoholic fatty liver disease by modulating gut microbiota

Yang Li, Danyang Zhao, Minyi Qian et al. · British Journal of Pharmacology · 2021 · 89 citations · Full text

, , +17

Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease

Minyi Qian, Jun Liu, Danyang Zhao et al. · Cellular and Molecular Gastroenterology and Hepatology · 2021 · 70 citations · Full text

, , +17

Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice

Minyi Qian, Qianqian Lyu, Yujie Liu et al. · Marine Drugs · 2019 · 62 citations · Full text

, , +17

Magnolol effectively ameliorates diabetic peripheral neuropathy in mice

Juanzhen Yang, Yuxi Wei, Tong Zhao et al. · Phytomedicine · 2022 · 56 citations

, , +10

Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis

Minyi Qian, Ying Yao, Danyang Zhao et al. · Liver International · 2019 · 54 citations

, , +17

1–5 of 16